Published in Transplantation on April 15, 2003
Long-term outcome of renal transplantation from older donors. N Engl J Med (2006) 5.10
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med (2004) 3.74
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood (2002) 3.59
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med (2002) 3.51
An association between atherosclerosis and venous thrombosis. N Engl J Med (2003) 3.39
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial. Lancet (2004) 2.38
12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients. Transpl Int (2007) 2.03
X-linked thrombophilia with a mutant factor IX (factor IX Padua). N Engl J Med (2009) 2.02
Hepatitis C virus infection in end-stage renal disease and kidney transplantation. Transpl Int (2014) 2.01
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. Blood (2008) 1.90
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood (2009) 1.80
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood (2002) 1.78
Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial. J Am Soc Nephrol (2007) 1.76
Acute rejection and graft survival in renal transplanted patients with viral diseases. Mod Pathol (2004) 1.51
Heterotopic cardiac xenotransplantation in rodents: report of a refined technique in a hamster-to-rat model. Microsurgery (2005) 1.47
Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis. Thromb Haemost (2003) 1.46
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation (2005) 1.39
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy. Minerva Anestesiol (2015) 1.39
The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified. J Thromb Thrombolysis (2009) 1.38
Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant (2004) 1.30
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood (2002) 1.23
Monolateral placement of both kidneys in dual kidney transplantation: low surgical complication rate and short operating time. Transpl Int (2006) 1.22
Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation (2003) 1.14
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Eur J Cancer (2012) 1.12
Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost (2006) 1.12
T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol (2008) 1.12
Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol (2008) 1.11
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab (2002) 1.10
Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood (2002) 1.02
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant (2005) 1.00
Esophageal achalasia: is the herpes simplex virus really innocent? J Gastrointest Surg (2004) 0.99
Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies. Am J Transplant (2004) 0.96
The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ (2004) 0.96
Outcome of renal transplantation from very old donors. N Engl J Med (2009) 0.96
C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost (2006) 0.95
Images in clinical medicine. Autosomal dominant polycystic kidney disease. N Engl J Med (2010) 0.95
ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome. J Am Soc Nephrol (2009) 0.94
The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost (2002) 0.93
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. Blood (2002) 0.93
Rebuttal: factor XII levels, factor XII 46 C>T polymorphism and venous thrombosis: a word of caution is needed. Thromb Haemost (2004) 0.92
The Mannich base NC1153 promotes long-term allograft survival and spares the recipient from multiple toxicities. J Immunol (2005) 0.91
Use of a BJAB-derived cell line for isolation of human herpesvirus 8. J Clin Microbiol (2005) 0.90
Ureteral stenosis in HDAF pig-to-primate renal xenotransplantation: a phenomenon related to immunological events? Am J Transplant (2004) 0.90
Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts. Transplantation (2005) 0.89
Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med (2002) 0.89
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res (2011) 0.89
Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. Transplantation (2006) 0.89
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol Dial Transplant (2007) 0.88
Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients. J Clin Microbiol (2013) 0.88
Kidney transplantation from anti-HBc+ donors: results from a retrospective Italian study. Transplantation (2006) 0.86
Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. Haematologica (2003) 0.86
A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine. Nephrol Dial Transplant (2007) 0.85
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results. Nephrol Dial Transplant (2008) 0.85
Thrombophilia as a predictor of persistent residual vein thrombosis. Haematologica (2008) 0.85
Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis (2003) 0.84
The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost (2003) 0.84
Does hemophilia protect against atherosclerosis? A case-control study. Clin Appl Thromb Hemost (2006) 0.83
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. Transplantation (2009) 0.83
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. Haemophilia (2011) 0.83
Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. Haematologica (2005) 0.83
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events. Thromb Haemost (2014) 0.82
Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency. J Bone Miner Res (2010) 0.82
Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. Transplantation (2006) 0.82
A single-center experience with 200 dual kidney transplantations. Clin Transplant (2014) 0.82
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood (2002) 0.82
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. Thromb Haemost (2004) 0.82
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. Blood (2002) 0.81
Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population. Thromb Haemost (2005) 0.81
Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes. Blood Coagul Fibrinolysis (2008) 0.81
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients. Pharmacol Res (2006) 0.80
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method. Clin Chem Lab Med (2015) 0.80
Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? Eur J Gastroenterol Hepatol (2006) 0.80
Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Thromb Haemost (2014) 0.80
Inherited thrombophilia and venous thromboembolism. Semin Thromb Hemost (2006) 0.80
Effects of long-term administration of recombinant human protein C in xenografted primates. Transplantation (2011) 0.79
Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency. Haematologica (2010) 0.79